4-[3-(1-hydroxyprop-2-enyl)-1-[(4-methoxyphenyl)methyl]pyrazol-4-yl]-1,3-thiazole-5-carbaldehyde
C18H17N3O3S — CID 123417164
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3-(1-hydroxyprop-2-enyl)-1-[(4-methoxyphenyl)methyl]pyrazol-4-yl]-1,3-thiazole-5-carbaldehyde
4-[3-(1-hydroxyprop-2-enyl)-1-[(4-methoxyphenyl)methyl]pyrazol-4-yl]-1,3-thiazole-5-carbaldehyde (PubChem CID 123417164) has the molecular formula C18H17N3O3S and a molecular weight of 355.42 g/mol. Its IUPAC name is 4-[3-(1-hydroxyprop-2-enyl)-1-[(4-methoxyphenyl)methyl]pyrazol-4-yl]-1,3-thiazole-5-carbaldehyde.
Molecular Properties
| Compound Name | 4-[3-(1-hydroxyprop-2-enyl)-1-[(4-methoxyphenyl)methyl]pyrazol-4-yl]-1,3-thiazole-5-carbaldehyde |
|---|---|
| PubChem CID | 123417164 |
| Molecular Formula | C18H17N3O3S |
| Molecular Weight | 355.42 g/mol |
| Exact Mass | 355.10 |
| IUPAC Name | 4-[3-(1-hydroxyprop-2-enyl)-1-[(4-methoxyphenyl)methyl]pyrazol-4-yl]-1,3-thiazole-5-carbaldehyde |
| SMILES | C=CC(O)c1nn(Cc2ccc(OC)cc2)cc1-c1ncsc1C=O |
| InChI | InChI=1S/C18H17N3O3S/c1-3-15(23)17-14(18-16(10-22)25-11-19-18)9-21(20-17)8-12-4-6-13(24-2)7-5-12/h3-7,9-11,15,23H,1,8H2,2H3 |
| InChIKey | MUGQVBDFTJWNFN-UHFFFAOYSA-N |
| XLogP | 3.10 |
| TPSA | 77.24 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 355.42 |
| LogP ≤ 5 | 3.10 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123417164 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.